Abbott Laboratories (ABT): Price and Financial Metrics

ABT POWR Grades

• ABT scores best on the Sentiment dimension, with a Sentiment rank ahead of 95.38% of US stocks.
• ABT's strongest trending metric is Value; it's been moving up over the last 48 weeks.
• ABT ranks lowest in Momentum; there it ranks in the 40th percentile.

ABT Stock Summary

• Abbott Laboratories's market capitalization of $220,981,682,553 is ahead of 99.1% of US-listed equities.
• Abbott Laboratories's stock had its IPO on January 1, 1986, making it an older stock than 92.67% of US equities in our set.
• In terms of volatility of its share price, ABT is more volatile than only 4.53% of stocks we're observing.
• Stocks that are quantitatively similar to ABT, based on their financial statements, market capitalization, and price volatility, are DHR, TMO, NVO, MDT, and VZ.
• ABT's SEC filings can be seen here. And to visit Abbott Laboratories's official web site, go to www.abbott.com.

ABT Valuation Summary

• ABT's price/earnings ratio is 35.1; this is 3.84% lower than that of the median Healthcare stock.
• Over the past 243 months, ABT's price/sales ratio has gone up 0.3.
• Over the past 243 months, ABT's price/earnings ratio has gone down 10.1.

Below are key valuation metrics over time for ABT.

ABT Growth Metrics

• Its 5 year price growth rate is now at 104.25%.
• Its 4 year revenue growth rate is now at 57.38%.
• Its year over year net income to common stockholders growth rate is now at 59.93%.

ABT's revenue has moved up $9,831,000,000 over the prior 33 months.

The table below shows ABT's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2021-06-30	40,233	10,629	6,376
2021-03-31	37,338	9,823	5,724
2020-12-31	34,608	7,901	4,495
2020-09-30	32,221	6,519	3,382
2020-06-30	31,444	6,401	3,110
2020-03-31	32,095	6,139	3,579

ABT's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ABT has a Quality Grade of B, ranking ahead of 76.55% of graded US stocks.
• ABT's asset turnover comes in at 0.559 -- ranking 68th of 677 Pharmaceutical Products stocks.
• DVAX, RARE, and CORT are the stocks whose asset turnover ratios are most correlated with ABT.

The table below shows ABT's key quality metrics over time.